SYMPLICITY HTN-3: failure at 6 months, success at 3 years?
- 18 September 2022
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 400 (10361), 1382-1383
- https://doi.org/10.1016/s0140-6736(22)01788-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialThe Lancet, 2022
- European Society of Hypertension position paper on renal denervation 2021Journal of Hypertension, 2021
- Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?Canadian Journal of Cardiology, 2015
- Renal Denervation after Symplicity HTN-3: An UpdateCurrent Hypertension Reports, 2014
- Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?European Heart Journal, 2014
- A Controlled Trial of Renal Denervation for Resistant HypertensionThe New England Journal of Medicine, 2014
- Catheter-Based Renal Sympathetic Denervation for Resistant HypertensionHypertension, 2011
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialThe Lancet, 2010
- Analytical approaches to reporting long-term clinical trial dataCurrent Medical Research and Opinion, 2008